Chargement en cours...
MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life
MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy.
Enregistré dans:
| Publié dans: | Clin Cancer Res |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911276/ https://ncbi.nlm.nih.gov/pubmed/27009743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0229 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|